DexTech Medical AB (FRA:LQ0) Beneish M-Score: 0.00 (As of Jul. 12, 2026)

What is DexTech Medical AB Beneish M-Score?

DexTech Medical AB FRA:LQ0 +3.33% 17 Beneish M-Score is 0.00 as of Jul. 12, 2026. GuruFocus rates FRA:LQ0 with a GF Score™ of 17/100. The stock has 3 warning signs investors should review. Among 825 Biotechnology companies, DexTech Medical AB ranks worse than 121212% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

The historical rank and industry rank for DexTech Medical AB's Beneish M-Score or its related term are showing as below:

During the past 13 years, the highest Beneish M-Score of DexTech Medical AB was -3.41. The lowest was -3.41. And the median was -3.41.

DexTech Medical AB Beneish M-Score Related Terms

DexTech Medical AB Beneish M-Score Historical Data

* Premium members only.

The historical data trend for DexTech Medical AB's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DexTech Medical AB Beneish M-Score Chart

DexTech Medical AB Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Jun25

Beneish M-Score

Get a 7-Day Free Trial

0.00

DexTech Medical AB Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Beneish M-Score	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

FRA:LQ0 vs VRTX, REGN, ALNY: Beneish M-Score Comparison

For the Biotechnology subindustry, DexTech Medical AB's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DexTech Medical AB Beneish M-Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, DexTech Medical AB's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where DexTech Medical AB's Beneish M-Score falls into.

Save Embed

17GF Score

DexTech Medical AB FRA:LQ0

Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

DexTech Medical AB Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of DexTech Medical AB for today is based on a combination of the following eight different indices:

-4.84

0.92 * DSRI

0.528 * GMI

0.404 * AQI

0.892 * SGI

0.115 * DEPI

-4.84

0.92 *

0.528 *

0.404 *

0.892 *

0.115 *

0.172 * SGAI

4.679 * TATA

0.327 * LVGI

0.172 *

4.679 *

0.327 *

This Year (Jun25) TTM:

Last Year (Jun24) TTM:

Total Receivables was €0.04 Mil.
Revenue was €0.00 Mil.
Gross Profit was €0.29 Mil.
Total Current Assets was €1.38 Mil.
Total Assets was €2.28 Mil.
Property, Plant and Equipment(Net PPE) was €0.00 Mil.
Depreciation, Depletion and Amortization(DDA) was €0.38 Mil.
Selling, General, & Admin. Expense(SGA) was €0.00 Mil.
Total Current Liabilities was €0.03 Mil.
Long-Term Debt & Capital Lease Obligation was €0.00 Mil.
Net Income was €-0.44 Mil.
Gross Profit was €0.00 Mil.
Cash Flow from Operations was €-0.10 Mil.

Total Receivables was €0.06 Mil.
Revenue was €0.00 Mil.
Gross Profit was €0.48 Mil.
Total Current Assets was €1.74 Mil.
Total Assets was €2.71 Mil.
Property, Plant and Equipment(Net PPE) was €0.00 Mil.
Depreciation, Depletion and Amortization(DDA) was €0.33 Mil.
Selling, General, & Admin. Expense(SGA) was €0.00 Mil.
Total Current Liabilities was €0.09 Mil.
Long-Term Debt & Capital Lease Obligation was €0.00 Mil.

1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI	=	(Receivables_t / Revenue_t)	/	(Receivables_t-1 / Revenue_t-1)
	=	(0.043 / 0)	/	(0.056 / 0)
	=		/
	=

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI	=	GrossMargin_t-1	/	GrossMargin_t
	=	(GrossProfit_t-1 / Revenue_t-1)	/	(GrossProfit_t / Revenue_t)
	=	(0.477 / 0)	/	(0.293 / 0)
	=		/
	=

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI	=	(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t)	/	(1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
	=	(1 - (1.379 + 0) / 2.279)	/	(1 - (1.743 + 0) / 2.71)
	=	0.39491	/	0.356827
	=

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI	=	Sales_t	/	Sales_t-1
	=	Revenue_t	/	Revenue_t-1
	=	0	/	0
	=

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI	=	(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1))	/	(Depreciation_t / (Depreciaton_t + PPE_t))
	=	(0.327 / (0.327 + 0))	/	(0.383 / (0.383 + 0))
	=	1	/	1
	=

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI	=	(SGA_t / Sales_t)	/	(SGA_t-1 /Sales_t-1)
	=	(0 / 0)	/	(0 / 0)
	=		/
	=

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI	=	((LTD_t + CurrentLiabilities_t) / TotalAssets_t)	/	((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
	=	((0 + 0.031) / 2.279)	/	((0 + 0.087) / 2.71)
	=	0.013602	/	0.032103
	=

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA	=	(IncomefromContinuingOperations_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(NetIncome_t - NonOperatingIncome_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(-0.44 - 0	-	-0.101)	/	2.279
	=	-0.148749

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →

What does a Beneish M-Score of 0.00 mean?

DexTech Medical AB (FRA:LQ0) has a Beneish M-Score of 0.00 as of Jul. 12, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on DexTech Medical AB and its competitors. According to the industry distribution chart, DexTech Medical AB ranks #999999 out of 825 companies in the Biotechnology industry.

Is DexTech Medical AB's Beneish M-Score too high?

DexTech Medical AB's current Beneish M-Score is 0.00. Based on the distribution chart, DexTech Medical AB ranks #999999 out of 825 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, DexTech Medical AB has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.

How does DexTech Medical AB's Beneish M-Score compare to VRTX and REGN?

According to the Biotechnology industry distribution chart, DexTech Medical AB ranks #999999 out of 825 companies for Beneish M-Score. This places DexTech Medical AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Beneish M-Score for a Biotechnology company?

A good Beneish M-Score depends on the Biotechnology industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Beneish M-Score mean?

A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on DexTech Medical AB and its competitors. DexTech Medical AB's current Beneish M-Score is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is DexTech Medical AB stock overvalued right now?

DexTech Medical AB (FRA:LQ0) has a current Beneish M-Score of 0.00. The current Beneish M-Score is 0.00. DexTech Medical AB's overall GF Score™ is 17/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Beneish M-Score calculated?

Beneish M-Score is calculated from a company's financial statements. For DexTech Medical AB (FRA:LQ0), the current Beneish M-Score is 0.00 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

DexTech Medical AB Business Description

Industry Healthcare Biotechnology

Comparable Companies OSTO:INIT OSTO:XINT XSAT:ABERA OSTO:ELIC OSTO:XBRANE OSTO:ISOFOL OSTO:KDV OSTO:NICA OSTO:DMYD B OSTO:ACTI VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Other Exchanges DEX:Sweden

Address Dag Hammarskjolds Vag 34A, Uppsala, SWE, 752 37

Website https://www.dextechmedical.com

DexTech Medical AB is a Swedish research company specializing in drug development for urological oncology, with a prominent focus on prostate cancer. The company develops drug candidates using a proprietary carbohydrate platform, advancing treatments aimed at castration-resistant prostate cancer and related conditions. Its operations center on research, development, and licensing of these drug candidates. It has four drug candidates: OsteoDex, SomaDex, PSMA-binding conjugates, and GuaDex.

17GF Score

Get the complete analysis for FRA:LQ0

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.87

Price

View FRA:LQ0 Analysis

See Beneish M-Score data for all stocks →